Morrison Foerster advised Hume AI Inc. on the deal. Hume AI Inc., a New York-based expressive communication research lab and startup, announced its $12.7 million Series...
Hume AI’s $12.7 Million Series A Investment
Xpansiv Limited’s Additional $125 Million Investment
Morrison Foerster advised Xpansiv Limited on the deal. Xpansiv Limited, an Australian-based premier infrastructure provider for environmental markets, announced an additional $125 million capital raise. The raise is...
MTY Food Group’s Acquisition of BBQ Holdings
Morrison Foerster advised MTY Food Group Inc. on the deal. MTY Food Group Inc. (TSX: MTY) announced its acquisition of BBQ Holdings, Inc. (NASDAQ: BBQ), a...
Foxen Holdings’ $44 Million Series A Financing
Morrison Foerster advised Foxen Holdings on the deal. Foxen Holdings announced its $44 million Series A financing. Foxen is a developer of proprietary technology designed to provide...
Code Biotherapeutics’ $75 Million Series A Financing
Morrison Foerster advised New Enterprise Associates, 4BIO Capital, and UPMC Enterprises on the deal. New Enterprise Associates, 4BIO Capital, and UPMC Enterprises acted as investors in...
9am.health’s $16 Million Series A Round
MoFo advised 9am.health on the deal. 9am.health completed its $16 million Series A financing round. 9am.health is a virtual diabetes clinic that offers personalized and affordable care...
Carlsmed’s $30 Million Series B Financing Round
MoFo advised Carlsmed on the deal. Carlsmed announced the completion of its $30 million Series B financing round. Carlsmed’s mission is to improve outcomes and decrease the...